BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership

Reuters

Jan 29

BUZZ-<a href="https://laohu8.com/S/RHYN.AU">Rhythm Biosciences</a> gains on Australian Genome Research Facility partnership

** Shares of Australia's Rhythm Biosciences RHY.AX rise as much as 16.7% to A$0.175, their highest level since January 16

** Medical diagnostics tech firm announces strategic partnership with Australian Genome Research Facility

** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services

** About 2.2 million shares traded so far, 2.6x the 30-day avg

** Stock up 22% in January so far, including the session's move

(Reporting by Anjali Singh in Bengaluru)

((anjali.singh2@thomsonreuters.com; ))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2607771970"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2607771970\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2607771970?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-29 12:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607771970","market":"fut","top_or_hot":-1,"title":"BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on Australian Genome Research Facility partnership </title></head><body><p>** Shares of Australia's <a href=\"https://laohu8.com/S/RHY.AU\">Rhythm Biosciences</a> <span>RHY.AX</span> rise as much as 16.7% to A$0.175, their highest level since January 16</p><p>\n    ** Medical diagnostics tech firm <span>announces</span> strategic partnership with Australian Genome Research Facility \n  </p><p>** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services</p><p>** About 2.2 million shares traded so far, 2.6x the 30-day avg</p><p>** Stock up 22% in January so far, including the session's move</p><p>(Reporting by Anjali Singh in Bengaluru)</p><p>((anjali.singh2@thomsonreuters.com; ))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-29 12:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> gains on Australian Genome Research Facility partnership </title></head><body><p>** Shares of Australia's <a href=\"https://laohu8.com/S/RHY.AU\">Rhythm Biosciences</a> <span>RHY.AX</span> rise as much as 16.7% to A$0.175, their highest level since January 16</p><p>\n    ** Medical diagnostics tech firm <span>announces</span> strategic partnership with Australian Genome Research Facility \n  </p><p>** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services</p><p>** About 2.2 million shares traded so far, 2.6x the 30-day avg</p><p>** Stock up 22% in January so far, including the session's move</p><p>(Reporting by Anjali Singh in Bengaluru)</p><p>((anjali.singh2@thomsonreuters.com; ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RHY.AU","symbol_name":"RHYTHM BIOSCIENCES LTD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nL6N3YU08W:1","article_id":"2607771970","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2607771970","pubTimestamp":1769660504,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership** Shares of Australia's Rhythm Biosciences RHY.AX rise as much as 16.7% to A$0.175, their highest level since January 16. ** Medical diagnostics tech firm announces strategic partnership with Australian Genome Research Facility. ** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services** About 2.2 million shares traded so far, 2.6x the 30-day avg** Stock up 22% in January so far, including the session's move","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RHY.AU":"RHYTHM BIOSCIENCES LTD","BK7124":"保健护理服务"},"translate_title":"BUZZ-Rhythm Biosciences从澳大利亚基因组研究机构合作中获益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RHY.AU":0.9},"content_text":"BUZZ-Rhythm Biosciences gains on Australian Genome Research Facility partnership ** Shares of Australia's Rhythm Biosciences RHY.AX rise as much as 16.7% to A$0.175, their highest level since January 16\n    ** Medical diagnostics tech firm announces strategic partnership with Australian Genome Research Facility \n  ** Partnership to establish commercial-scale processing capability for its predictive diagnostic tests platform, geneType, clinical services** About 2.2 million shares traded so far, 2.6x the 30-day avg** Stock up 22% in January so far, including the session's move(Reporting by Anjali Singh in Bengaluru)((anjali.singh2@thomsonreuters.com; ))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}